Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Phathom Pharmaceuticals (PHAT) Long-Term Debt Issuances (2023 - 2024)

Phathom Pharmaceuticals (PHAT) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $24.8 million as the latest value for Q4 2024.

  • On a quarterly basis, Long-Term Debt Issuances fell 37.05% to $24.8 million in Q4 2024 year-over-year; TTM through Sep 2025 was $24.8 million, a 66.54% decrease, with the full-year FY2024 number at $59.4 million, up 51.08% from a year prior.
  • Long-Term Debt Issuances was $24.8 million for Q4 2024 at Phathom Pharmaceuticals, roughly flat from $24.8 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $39.3 million in Q4 2023 to a low of $9.9 million in Q1 2024.